Evidence map›Paper›PMID 36016184›Full record

ArticleVaccines2022

Efficient Oral Priming of

Sergio González-Acosta, Victoria Baca-González, Patricia Asensio-Calavia, Andrea Otazo-Pérez, Manuel R López, Antonio Morales-delaNuez, José Manuel Pérez de la Lastra

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Crosstalk BetweenInsects · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sergio González-AcostaBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0002-6012-8255
Victoria Baca-GonzálezBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0001-7195-7211
Patricia Asensio-CalaviaBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0001-8413-8426
Andrea Otazo-PérezBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0002-4437-3832
Manuel R LópezBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0001-7519-4610
Antonio Morales-delaNuezBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0002-0184-2037
José Manuel Pérez de la LastraBiotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, (IPNA-CSIC), 38206 San Cristóbal de la Laguna, Spain.ORCID 0000-0003-4663-5565
Instituto de Productos Naturales y Agrobiología · ESUniversidad de La Laguna · ES

Funding

Agencia Canaria de Investigación, Innovación y Sociedad de la Información ProID2020010134Cooperation Program INTERREG-MAC 2014-2020 APOGEOFundación CajaCanarias 2019SP43
6 · The paper itself

Abstract

Microbial resistance is a global health problem that will increase over time. Advances in insect antimicrobial peptides (AMPs) offer a powerful new approach to combat antimicrobial resistance. Invertebrates represent a rich group of animals for the discovery of new antimicrobial agents due to their high diversity and the presence of adaptive immunity or "immune priming". Here, we report a priming approach for

Indexed as

antimicrobial peptidesimmune priminginvertebrate immunityin vitro antimicrobial assaymealwormssurvival rate

Identifiers

PMID36016184
PMCPMC9415734
OpenAlexW4291161864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.